Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Capital Expenditures (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Capital Expenditures for 11 consecutive years, with $52483.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures fell 95.16% to $52483.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $481168.0, a 68.7% decrease, with the full-year FY2024 number at $1.3 million, up 65.71% from a year prior.
  • Capital Expenditures was $52483.0 for Q3 2025 at KORU Medical Systems, up from $28814.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q2 2022 to a low of -$43567.0 in Q4 2024.
  • A 5-year average of $300649.7 and a median of $149497.0 in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: skyrocketed 1951.92% in 2022, then crashed 122.22% in 2024.
  • KORU Medical Systems' Capital Expenditures stood at $44458.0 in 2021, then soared by 393.42% to $219363.0 in 2022, then fell by 10.63% to $196052.0 in 2023, then tumbled by 122.22% to -$43567.0 in 2024, then surged by 220.47% to $52483.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Capital Expenditures are $52483.0 (Q3 2025), $28814.0 (Q2 2025), and $443438.0 (Q1 2025).